CytomX Therapeutics, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+19.2% +$5M
$-21M
Free Cash Flow↓-151.3% -$121K
$-201K
Investing Cash Flow↓-97.6% -$18M
$439K
Financing Cash Flow↑+640.0% +$14M
$17M